As regulatory requirements tighten and operational complexities increase, many IDN pharmacies are turning to centralized sterile compounding centers to enhance quality control, improve efficiency, and ensure compliance. These centers offer opportunities to standardize practices, reduce site-level burden, and create scalable models for sterile medication preparation—but require significant planning, oversight, and investment.

Join pharmacy experts as they share their experiences implementing and managing centralized compounding centers and explore the opportunities and challenges that this could pose to your organization.

Learning Objectives:
1. Describe the strategic role of centralized sterile compounding centers within an IDN.
2. Evaluate the clinical, operational, and regulatory considerations involved in developing and maintaining centralized sterile compounding centers.
3. Identify key benefits and challenges associated with shifting from site-level to centralized sterile compounding.
4. Formulate an implementation roadmap for organizations considering a transition to centralized compounding models.